Search Results 751-760 of 12014 for Lupus

1. Laboratories - Mayo Clinic Research

   Pancreatitis and Acute Outcomes Research: Vijay P. · Parkinson's Disease and Movement Disorders: Charles H. · Parkinson's Disease: Owen A. · Pediatric Anxiety ...

2. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Mayo Clinic

   - Active, known or suspected autoimmune disease, including systemic lupus erythematosus, Hashimotos thyroiditis, scleroderma, polyarteritis nodosa or autoimmune ...

3. Laboratories - Mayo Clinic Research

   Immuno-Epigenetics: William A. · Immunometabolism and Cancer Immunology: Marion R. · Infection and Immunity: Raymund R. · Infectious Diseases: Robin Patel ...

4. Overview - Human Integrative and Environmental Physiology Lab: Bruce D. Johnson - Mayo Clinic Research

   The Human Integrative and Environmental Physiology Laboratory, led by principal investigator Bruce D. Johnson, Ph.D., researches human health and disease in ...

5. PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Active systemic autoimmune disease or a history of autoimmune disorder that may relapse (e.g., systemic lupus erythematosus [SLE], rheumatoid arthritis ...

6. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. MOTUS Total Joint Replacement Investigational Device Exemption Study - Mayo Clinic

   Systemic disease including Lupus disease, Reiter's disease, Rheumatoid disease, AIDS, HIV, hepatitis or autoimmune disease that requires immunosuppressive ...

8. Overview - Neurobiology of Parkinson's Disease Laboratory - Mayo Clinic Research

   At Mayo Clinic, the McLean lab uses viral vector gene delivery to model neurodegenerative disease. Modeling diseases using viral vectors. The McLean lab uses ...

9. Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

   Diagnosis of autoimmune disease (i.e., rheumatoid arthritis, scleroderma, systemic lupus erythematosus [SLE], autoimmune vasculitis, Guillain-Barre syndrome, ...

10. Alzheimer's disease - Doctors and departments - Mayo Clinic

    Understand more about this brain disorder that's the most common cause of dementia. Also learn about new tests and medicines on the market.